These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28135059)

  • 1. Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents.
    Carbajales C; Sawada JI; Marzaro G; Sotelo E; Escalante L; Sánchez-Díaz Marta A; García-Mera X; Asai A; Coelho A
    ACS Comb Sci; 2017 Mar; 19(3):153-160. PubMed ID: 28135059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPUYJ039, a newly synthesized benzimidazole-based compound, is proved to be a novel inducer of apoptosis in HCT116 cells with potent KSP inhibitory activity.
    Jiang C; Yang L; Wu WT; Guo QL; You QD
    J Pharm Pharmacol; 2011 Nov; 63(11):1462-9. PubMed ID: 21988427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reaction.
    Carbajales C; Prado MÁ; Gutiérrez-de-Terán H; Cores A; Azuaje J; Novio S; Nuñez MJ; Fernández-García B; Sotelo E; García-Mera X; Sánchez-Lazo P; Freire-Garabal M; Coelho A
    Chembiochem; 2014 Jul; 15(10):1471-80. PubMed ID: 24943831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicomponent reactions in antimitotic drug discovery.
    Cores A; Carbajales C; Coelho A
    Curr Top Med Chem; 2014; 14(20):2209-30. PubMed ID: 25440494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of biphenyl compounds as kinesin spindle protein inhibitors.
    Holland JP; Kang A; Cohrs S; Selivanova SV; Milicevic Sephton S; Betzel T; Frey D; Wieser M; Jaussi R; Kammerer RA; Schibli R; Fischer E
    Chem Biodivers; 2013 Apr; 10(4):538-55. PubMed ID: 23576341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary isonitrile-based multicomponent reactions for the synthesis of diversified cytotoxic hemiasterlin analogues.
    Lesma G; Bassanini I; Bortolozzi R; Colletto C; Bai R; Hamel E; Meneghetti F; Rainoldi G; Stucchi M; Sacchetti A; Silvani A; Viola G
    Org Biomol Chem; 2015 Dec; 13(48):11633-44. PubMed ID: 26467486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSP inhibitors as antimitotic agents.
    Pérez-Melero C
    Curr Top Med Chem; 2014; 14(20):2286-311. PubMed ID: 25434354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.
    Labrière C; Talapatra SK; Thoret S; Bougeret C; Kozielski F; Guillou C
    Bioorg Med Chem; 2016 Feb; 24(4):721-34. PubMed ID: 26778612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP.
    Coleman PJ; Schreier JD; Cox CD; Fraley ME; Garbaccio RM; Buser CA; Walsh ES; Hamilton K; Lobell RB; Rickert K; Tao W; Diehl RE; South VJ; Davide JP; Kohl NE; Yan Y; Kuo L; Prueksaritanont T; Li C; Mahan EA; Fernandez-Metzler C; Salata JJ; Hartman GD
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5390-5. PubMed ID: 17761419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in discovery and development of antimitotic agents.
    Kiselyov A; Balakin KV; Tkachenko SE; Savchuk N; Ivachtchenko AV
    Anticancer Agents Med Chem; 2007 Mar; 7(2):189-208. PubMed ID: 17348827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
    Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MAC1: A Small Molecule That Rescues Spindle Bipolarity in Monastrol-Treated Cells.
    Al-Obaidi N; Mitchison TJ; Crews CM; Mayer TU
    ACS Chem Biol; 2016 Jun; 11(6):1544-51. PubMed ID: 27121275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain.
    Sheth PR; Shipps GW; Seghezzi W; Smith CK; Chuang CC; Sanden D; Basso AD; Vilenchik L; Gray K; Annis DA; Nickbarg E; Ma Y; Lahue B; Herbst R; Le HV
    Biochemistry; 2010 Sep; 49(38):8350-8. PubMed ID: 20718440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors.
    Lahue BR; Ma Y; Shipps GW; Seghezzi W; Herbst R
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3405-9. PubMed ID: 19481450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
    Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
    J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of antimitotic polyalkoxyphenyl derivatives of combretastatin using plant allylpolyalkoxybenzenes.
    Semenov VV; Kiselyov AS; Titov IY; Sagamanova IK; Ikizalp NN; Chernysheva NB; Tsyganov DV; Konyushkin LD; Firgang SI; Semenov RV; Karmanova IB; Raihstat MM; Semenova MN
    J Nat Prod; 2010 Nov; 73(11):1796-802. PubMed ID: 21049975
    [No Abstract]   [Full Text] [Related]  

  • 18. High-throughput-screening-based identification and structure-activity relationship characterization defined (S)-2-(1-aminoisobutyl)-1-(3-chlorobenzyl)benzimidazole as a highly antimycotic agent nontoxic to cell lines.
    Bauer J; Kinast S; Burger-Kentischer A; Finkelmeier D; Kleymann G; Rayyan WA; Schröppel K; Singh A; Jung G; Wiesmüller KH; Rupp S; Eickhoff H
    J Med Chem; 2011 Oct; 54(19):6993-7. PubMed ID: 21711055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
    Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL
    Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinesin motor proteins as targets for cancer therapy.
    Huszar D; Theoclitou ME; Skolnik J; Herbst R
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):197-208. PubMed ID: 19156502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.